Cargando…

Switching and Combining Device-Aided Therapies in Advanced Parkinson’s Disease: A Double Centre Retrospective Study

Background: Device-aided therapies (DAT), such as continuous subcutaneous apomorphine infusion (CSAI), levodopa-carbidopa intestinal gel infusion (LCIG), and deep brain stimulation of the subthalamic nucleus (STN-DBS), have markedly changed the treatment landscape of advanced Parkinson’s disease (aP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Georgiev, Dejan, Delalić, Sentilija, Zupančič Križnar, Nina, Socher, Achinoam, Gurevich, Tanya, Trošt, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946829/ https://www.ncbi.nlm.nih.gov/pubmed/35326299 http://dx.doi.org/10.3390/brainsci12030343

Ejemplares similares

Parkinson's disease in a patient with multiple sclerosis and heterozygous glucocerebrosidase gene mutation
por: Delalić, Sentilija, et al.
Publicado: (2020)

Personality Changes After Subthalamic Nucleus Stimulation in Parkinson’s Disease
por: Brezovar, Simon, et al.
Publicado: (2022)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

A single-center real-life study on the use of medical cannabis in patients with dystonia
por: Anis, Saar, et al.
Publicado: (2023)

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease
por: Thaler, Avner, et al.
Publicado: (2022)

Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single‐center long‐term follow‐up study
por: Rus, Tomaž, et al.
Publicado: (2022)

Close relationships in Parkinson´s disease patients with device‐aided therapy
por: Scharfenort, Monica, et al.
Publicado: (2021)

Managing Device‐Aided Treatments in Parkinson's Disease in Times of COVID‐19
por: Abate, Filomena, et al.
Publicado: (2020)

Daily Habits in Parkinson's Disease: Validation of the Daily Habit Scale
por: Georgiev, Dejan, et al.
Publicado: (2023)

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies
por: Trošt, Maja, et al.
Publicado: (2019)

Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes
por: Zlotnik, Yair, et al.
Publicado: (2015)

Risk of Parkinson Disease Among Adults With vs Without Posttraumatic Stress Disorder
por: Barer, Yael, et al.
Publicado: (2022)

Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?
por: Redenšek, Sara, et al.
Publicado: (2017)

Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review
por: Smilowska, Katarzyna, et al.
Publicado: (2021)

Infusion Therapies in the Treatment of Parkinson’s Disease
por: van Laar, Teus, et al.
Publicado: (2023)

A single centre prospective study of three device-assisted therapies for Parkinson’s disease
por: Morales-Briceño, Hugo, et al.
Publicado: (2023)

Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease
por: Kedmi, Merav, et al.
Publicado: (2011)

Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson’s Disease
por: Levstek, Tina, et al.
Publicado: (2021)

Clinical-Pharmacogenetic Predictive Models for Time to Occurrence of Levodopa Related Motor Complications in Parkinson’s Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study
por: Fründt, Odette, et al.
Publicado: (2023)

In Parkinson’s disease on a probabilistic Go/NoGo task deep brain stimulation of the subthalamic nucleus only interferes with withholding of the most prepotent responses
por: Georgiev, Dejan, et al.
Publicado: (2016)

Protection devices and systems for high voltage applications
por: Gurevich, Vladimir
Publicado: (2002)

AID function in somatic hypermutation and class switch recombination: AID function in somatic hypermutation and class switch recombination
por: Yu, Kefei
Publicado: (2022)

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson’s Disease
por: Redenšek, Sara, et al.
Publicado: (2020)

Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study
por: Peretz, Chava, et al.
Publicado: (2016)

Statin adherence and the risk of Parkinson's disease: A population-based cohort study
por: Rozani, Violetta, et al.
Publicado: (2017)

Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson’s Disease and Dopaminergic Treatment Adverse Events
por: Redenšek, Sara, et al.
Publicado: (2022)

Multidisciplinary Intensive Rehabilitation Program for People with Parkinson’s Disease: Gaps between the Clinic and Real-World Mobility
por: Cohen, Moriya, et al.
Publicado: (2023)

Subthalamic Neurons Encode Both Single- and Multi-Limb Movements in Parkinson’s Disease Patients
por: Tankus, Ariel, et al.
Publicado: (2017)

Serotonin-Related Functional Genetic Variants Affect the Occurrence of Psychiatric and Motor Adverse Events of Dopaminergic Treatment in Parkinson’s Disease: A Retrospective Cohort Study
por: Redenšek, Sara, et al.
Publicado: (2022)

Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review
por: Moes, Harmen R., et al.
Publicado: (2023)

Metabolic Brain Changes Can Predict the Underlying Pathology in Neurodegenerative Brain Disorders: A Case Report of Sporadic Creutzfeldt–Jakob Disease with Concomitant Parkinson’s Disease
por: Rus, Tomaž, et al.
Publicado: (2023)

Impact of Subthalamic Deep Brain Stimulation Frequency on Upper Limb Motor Function in Parkinson’s Disease
por: Momin, Sheikh, et al.
Publicado: (2018)

Multi-Physical Models of Bending Characteristics on the Double-Clamped Beam Switch for Flexible Electronic Devices Application
por: Han, Lei, et al.
Publicado: (2020)

Noncommutative Switching of Double Spiropyrans
por: Kortekaas, Luuk, et al.
Publicado: (2020)

Bacterial microleakage of temporary filling materials used for endodontic access cavity sealing
por: Križnar, Igor, et al.
Publicado: (2016)

The Role of Genetic Data in Selecting Device-Aided Therapies in Patients With Advanced Parkinson’s Disease: A Mini-Review
por: Chan, Germaine Hiu-Fai
Publicado: (2022)

Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty
por: Auffret, Manon, et al.
Publicado: (2023)

Epigenetic tethering of AID to the donor switch region during immunoglobulin class switch recombination
por: Jeevan-Raj, Beena Patricia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m4dqpd50oit9893kqmbauf60mj